---
$id: https://graph.org.ai/products/commodity/51111613
$type: Product
source: UNSPSC
code: "51111613"
title: "Lenograstim"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Lenograstim

**UNSPSC Code**: 51111613
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a recombinant protein and Immunologic adjuvant with the molecular formula C9H14N4O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6WS4C399GB. European Medicines Agency schedules Lenograstim in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02888MIG. The term LENOGRASTIM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31.). World Health Organization schedules lenograstim in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule lenograstim under HS 30012010 and SITC 54162. As of Q4 2014, LENOGRASTIM remains the US FDA Preferred Term for this commodity. Lenograstim bears US NLM identifiers UMLS ID C0218640 and NCI Concept Code C49234. SMILES: N/A.

